Last updated: 2026-10-13 05:04:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Dolby Laboratories, Inc. (DLB) operates in the PATENT OWNERS & LESSORS sector and is listed on NYSE. The stock is currently priced at $58.06, with a market capitalisation of $5.50B and a P/E ratio of 24.33. Over the past 52 weeks, its price has ranged from $48.26 to $69.95. This page covers its latest market performance, valuation, price trends and company information.
$5.50B | |
$59.03 | |
$104.74 | |
$14.50 | |
$58.74 | |
396.27K | |
934.62K | |
24.33 | |
$69.95 | |
$48.26 | |
2.44% | |
-- |
Dolby Laboratories, Inc. (DLB) last closed at $58.74 as of 2026-10-12 23:31:00, unchanged from the previous close of $58.74.
During the latest regular trading session, DLB traded between $14.50 and $104.74, with a volume of 396.27K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Dolby Laboratories, Inc. (DLB) moved from $59.06 to $58.06, representing a decline of 1.69% ($1.00).
The stock traded between $57.53 and $59.68 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 741.25 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 45.2%
DLB is currently trading at $58.06, placing it 45.2% of the way from its 52-week low of $48.26 to its 52-week high of $69.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
| Industry | PATENT OWNERS & LESSORS |
| Employees | 2051 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Dolby Laboratories, Inc. (DLB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.